PATENT CLAIM ANALYSIS

Application Number: 16181651
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-08
Patent Classification: ["514", "183000"]

Abstract:
Methods of treating bladder cancer using terconazole are disclosed herein. Terconazole can be administered as part of a comprehensive treatment program, which can also include chemotherapy, immunotherapy, radiation therapy and/or surgical treatment.

Claim (Index 8):
The method according to  claim 4 , wherein the surgery comprises TURBT, partial or radical cystectomy.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 98.0
- Lexical Diversity: 1.19355
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15370393', '15651060', '15653814', '13814446', '12811321']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7680320431652153
- 35 USC 102 Novelty (BERT): 0.552256828116252
- Combined Prediction Score: 0.746454521660319
- Mean Citation Score: 216.43523
- Max Citation Score: 425.17264000000006
- Similarity Product: 289.8495869376278

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test